Is CRISPR Therapeutics AG technically bullish or bearish?

Nov 03 2025 11:34 AM IST
share
Share Via
As of October 31, 2025, CRISPR Therapeutics AG shows a bullish technical trend, with strong performance indicators despite some mixed signals, having returned 62.58% year-to-date and 37.94% over the past year, significantly outperforming the S&P 500.
As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the KST and Dow Theory show mixed signals with the weekly readings being mildly bearish. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, while the OBV is mildly bullish as well.

In terms of performance, the stock has returned 62.58% year-to-date and 37.94% over the past year, significantly outperforming the S&P 500, which returned 16.30% and 19.89% respectively during the same periods. Overall, the current technical stance is bullish, with moderate strength indicated by the mixed signals from some indicators.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News